Part of Thermo Fisher Scientific

Remel is a world-class microbiology brand. As a trusted supplier of a broad range of high quality media and diagnostic products used in clinical, industrial, research, and academic laboratories, and backed by a team of service experts, we are dedicated to microbiology.

Not sure where to go?

For product support, please contact Technical Service. Contact Customer Service to place an order or inquire about order status.

News Releases

Xpect Flu A&B Assay Achieves FDA Clearance for Novel Avian Influenza A (H7N9) Analytical Reactivity Label Claims

10/1/2013

<p>Analytical sensitivity data shows Thermo Fisher Scientific’s Remel Xpect Flu A&B assay is able to detect cultured avian influenza A (H7N9), A/Anhui/1/2013 virus. Analytical reactivity testing for this novel strain is in line with the FDA reclassification proposal for assessing detection of emerging viruses that could potentially cause a public health emergency.</p> <p>An outbreak in April of the novel influenza A (H7N9) virus infected more than 130 people, and resulted in at least 43 deaths<SUP>1</SUP>. While human infections have been limited to China, officials are remaining vigilant in monitoring the virus due to the pandemic potential.</p> <p>Rapid laboratory results from Xpect Flu A&B facilitate early diagnosis and identification of patients who may benefit from appropriate antiviral treatment. This not only has the potential to shorten the duration and severity of illness, but also reduces the misuse of antibiotics.</p> <p>“Rapid influenza tests provide quick and clinically useful results to allow for proper treatment on an individual level and an appropriate response at the public health level, which is imperative when managing a novel and particularly virulent virus,” stated Rob Spignesi, vice president and general manager for Microbiology, Americas, for Thermo Fisher Scientific. “Ensuring our Xpect Flu A&B assay effectively detects emerging and potentially threatening influenza viruses is a top priority for Thermo Fisher Scientific, and being able to add this information to label claims is an important accomplishment that we are proud to announce.”</p> <p>While Xpect Flu A&B can distinguish influenza A and influenza B, it cannot differentiate influenza subtypes, such as influenza A (H7N9). Performance with clinical specimens from patients infected with influenza A (H7N9) has not been established.</p> <p>In addition to the Xpect Flu A&B assay, Thermo Fisher Scientific provides a broad range of products for respiratory testing, including Xpect RSV, MicroTestTM viral transport, and collection swabs.</p> <P><sup>1</sup> <a href = "http://www.cdc.gov/flu/avianflu/h7n9-virus.htm"> cdc.gov/flu/avianflu/h7n9-virus</a> as of August 6, 2013</p>

...read more ...

Xpect<sup>&reg;</sup> Flu A&B IFU with FDA clearance to include new analytical reactivity information for avian influenza A virus (H7N9).

7/16/2013

<p>The Xpect<sup>&reg;</sup> Flu A&B Instructions for Use (package insert) has been revised to include additional analytical reactivity information for the H7N9 strain of the avian influenza A virus.</p> <p>Although Xpect Flu A&B has been shown to detect the novel influenza (H7N9) virus in cultured isolates from a positive human specimen, the performance characteristics of the device with human specimens infected with the 2013 avian influenza A (H7N9) virus have not been established. Xpect Flu A&B can distinguish between influenza A and B viruses, but it does not differentiate influenza subtypes.</p> <br /><br />

...read more ...

Sign-up for Paperless Invoices Today!

4/15/2011

<p>We now offer customers a free service that allows you to receive invoices via e-mail. With paperless invoices you will get invoices 7-10 days faster than traditional mail while helping to reduce the impact of paper on the environment.</p> <p>Getting started is easy. Simply <a href="[PATH]Support/PaperlessInvoices.aspx">sign-up</a> and start receiving invoices by e-mail within 1-3 days.</p> <br /> <p>If at any time you would like to return to receiving your invoices by traditional mail, simply contact a <a href="[PATH]Support/CustomerService.aspx">customer service representative</a>.</p> <br />

...read more ...

Introducing Thermo Scientific PathoProof Mastitis PCR Assays

4/7/2011

<p>LENEXA, Kan., (April 7, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the availability of Thermo Scientific PathoProof PCR assays for the U.S. dairy industry. PathoProof is a new line of advanced assays for detecting mastitis-causing bacteria in milk samples. These molecular-based assays improve the quality of our dairy supply by identifying mastitis-causing bacteria in just four hours, compared to days for traditional methods, providing dairy testing laboratories with convenient, fast and accurate test results. Because PathoProof assays rely on DNA, users can perform tests on multiple types of milk samples, including quarter milk samples, milk recording samples, and bulk tank samples, making it easier than ever to manage the costly effects of bovine mastitis.</p> <br/> <p>PathoProof Complete-12 and PathoProof Major-3 Mastitis PCR assays remove barriers to mastitis testing by providing more flexibility in sample types and eliminating the need to specially handle samples. It allows dairy farmers and laboratories to manage positive results in hours instead of days or weeks. The high sensitivity and objective test results possible with PathoProof take the guesswork out of mastitis testing, leading to better herd management. </p> <br /> <p>“The benefits of PathoProof over traditional bacterial culturing for identification of mastitis-causing bacteria are tremendous,” said Sumi Thaker, vice president marketing for Thermo Fisher’s Microbiology business. “Bovine mastitis is responsible for huge losses each year to the dairy industry. Total losses in the US alone exceed $2 billion. It’s time to replace the current method with a new gold standard that improves the quality of our dairy supply faster, more conveniently and with more accuracy.”</p> <br /> <p><a href="[PATH]promotions/pathoproof">Learn more</a></p> <br />

...read more ...

Find the right microbiology product with our online Product Usage Guide!

2/16/2011

<div><p>To help you choose the appropriate Remel or Oxoid brand microbiology product for your laboratory, we have created a user-friendly online version of our popular Product Usage Guide. This new web tool allows you to easily and quickly match your needs to our high quality microbiology products. While not all inclusive, our Product Usage Guide can be used as a quick reference for pathogen specific products and ordering information. It is part of our commitment to provide quality products, on-time delivery, and excellent customer service.</p> <br /> <p>Check out the <a href="[PATH]catalog/ProductUsageGuide.aspx">Product Usage Guide.</a></p> <br /></div>

...read more ...

Xpect<sup>&reg;</sup> RSV IFU Update

1/13/2011

<div><p>Updated Xpect<sup>&reg;</sup> RSV IFU effective immediately with the following changes:</p> <br /> <p><b>Materials Required But Not Provided Section: <br /> External positive and negative controls (optional) (REF R246012)</b></p><br /> <p><b>Test Procedure Section:</b> <br />Read results at 15 minutes. <b>Do not interpret results after 15 minutes.</b> <br />NOTE: If sample is mucoid or bloody, add 250 µl (second graduated line on a pipette) of the nasopharyngeal wash specimen to an extraction tube. Add 2 drops of Xpect RSV Extraction Buffer, insert filter cap, and mix. Dispense 3-4 drops of extracted specimen from extraction tube into a fresh test device. Some positive results may be seen within 30 seconds depending on specimen antigen concentration. Do not read results after <b>15 minutes</b>. <br /></p> <br /><p><b>Reporting Results Section:</b> <br />Invalid Test: <br />The test is invalid if no colored line appears in the C region (control) even if a colored line appears in the S region (specimen). If this occurs, the test is invalid and should be repeated. Colored lines that appear after <b>15 minutes</b> are not diagnostic and should be ignored.</p> </ul> </div> <br /> <br /> <p>Please contact Remel <a href="[PATH]Support/TechSupport.aspx">Technical Service</a> at 800.255.6730 if you have any questions or require any assistance with Remel products. </p> <br /> <br />

...read more ...

Spectra&trade; MRSA Now FDA Cleared to Detect MRSA Bloodstream Infections

10/27/2010

<div> <p><strong><i>Spectra MRSA is now available to detect MRSA bloodstream infections 24 hours faster than traditional methods, allowing for more targeted antibiotic therapy and improved patient outcomes</i>.</strong></p> <br /> <p>LENEXA, Kan., (October 27, 2010) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has received U.S. Food and Drug Administration (FDA) clearance of additional claims for <a href="http://www.remel.com/HAI/MRSA.aspx"> Spectra&trade; MRSA</a>, a test designed to screen for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). Spectra MRSA is now available for the qualitative detection of MRSA from positive blood cultures demonstrating Gram-positive cocci on Gram stain.</p> <br /><p>Bloodstream infections with MRSA can cause significant morbidity and mortality, resulting in considerable healthcare-related costs. The ability to rapidly differentiate MRSA is critical as it affects decisions on a patient’s antibiotic therapy and treatment regimen. Early recognition of MRSA bloodstream infections is important for patient management and infection control. Spectra MRSA can detect MRSA bloodstream infection 24 hours faster than traditional methods, allowing more targeted antibiotic therapy to improve patient outcomes. It offers flexibility for detection of MRSA in all commercial blood culture systems.</p> <br /><p>“The need for more aggressive prevention measures to quickly identify and stop the spread of MRSA is critical to reduce healthcare-associated infections in clinical settings, and hospitals need cost-effective solutions for improving patient outcomes,” said Mary Jo Deal, vice president and general manager of Thermo Fisher Scientific, Microbiology Americas. “Spectra MRSA is the first and only chromogenic media to offer results in 24 hours for both active surveillance of MRSA and detection of MRSA from positive blood cultures, resulting in a simple, economical solution that easily fits into routine laboratory testing procedures.” </p> <br /><p>Spectra MRSA is a ready-to-use, labor-saving test that can be easily adopted in healthcare facilities to aid in appropriate patient management. The test medium is easy to read, with MRSA appearing as distinctive denim blue colonies on a white background. Its use can help to simplify MRSA screening and testing and allow patient testing to continue 24 hours a day, seven days a week.</p> <br /><p>Spectra MRSA is manufactured and distributed by Thermo Fisher Scientific, widely known for its specialty brands Remel and Oxoid. To learn more about Spectra MRSA, visit <a href="http://www.remel.com/HAI"target="_blank">www.remel.com/hai</a>.</p> <br /><p><strong>About Thermo Fisher Scientific</strong></p> <p>Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.</p> <br /> </div>

...read more ...

New HAI Microsite. Watch the Video.

10/26/2010

<div> <p><b> Introducing a new website dedicated to providing education and product solutions for Healthcare Associated Infections.</b></p> <br /> <p>Infection prevention starts with preparation. That's why we developed a site dedicated to serving microbiologists and infection prevention practitioners in their quest to reduce hospital costs and improve patient safety. Designed to educate customers on issues related to Healthcare Associated Infections, the microsite provides information and tools for MRSA screening, <i>C. diff</i> testing and VRE screening.</p> <br /> <p>To help control the spread of these dangerous infections, we provide a full suite of high-performance products including Spectra<sup>&trade;</sup> MRSA, Xpect<sup>&reg;</sup> C. difficile Toxin A/B and Spectra<sup>&trade;</sup> VRE.</p> <br /> <p> <a href="[PATH]HAI/video.aspx"> <img src="[PATH]images/promo/watch-vid.jpg" /></a></p> <br /> <br /> <br /> </div>

...read more ...

Check out the MRSA Screening Cost Analyzer

10/4/2010

<div> <p>The MRSA Screening Cost Analyzer evaluates the economic implications of MRSA screening in your hospital. This model estimates the cost and outcome implications of the various methods of screening MRSA, taking into account whether or not hospitals are prepared to act immediately upon screening results. </p> <br /> <p><b>Why is MRSA Screening Important?</b> </p> <ul> <li>Once colonized with MRSA, 30-50% of patients become infected.<sup class="superscript">1,2</sup></li> <li>MRSA costs U.S. hospitals $3.2 - $4.2 Billion annually, and patients with MRSA spend up to 10 days longer in the hospital than those with methicillin-sensitive <i>Staphylococcus aureus</i> infections.<sup class="superscript">3</sup></li> <li>Active MRSA screening programs are important for the control and prevention of MRSA.</li></ul> <br /> <a href="[PATH]HAI/MRSASCAnalyzer.aspx"> <img src="[PATH]HAI/assets/images/cost-analyzer.jpg" /></a> <br /> <br /> <p><a href="[PATH]HAI/MRSA.aspx">Learn more</a> about Spectra&trade; MRSA and other Remel solutions for hospital associated infections.</p> <br /> <p><b>References</b></p> <p><sup class="superscript">1</sup>Hall G., and D. flayhart. Infection Control Today; February 2006. </p> <p><sup class="superscript">2</sup>Klevens, R.M. et. Al. Clinical Infectious Disease 2006; 42:389-91.</p> <p><sup class="superscript">3</sup>U.S. Outcomes Research Group of Pfizer Inc. Presented at the International Society for Pharmacoeconomics Outcome Research Meeting; 2005. </p> </div>

...read more ...

Spectra UTI&trade; chromogenic medium improves work flow and saves time in urine testing

9/28/2010

<div><p>Microbiological examination of urine is one of the most frequently requested tests in the clinical microbiology laboratory and contributes significantly to the daily workload. Of the cultures which are positive for growth, 60-70% will yield <i>E. coli</i>, and 10-15% will yield enterococci, and both can be confirmed using <b>Spectra UTI</b> in just 24 hours. Traditional culture media, such as Blood Agar and MacConkey Agar, have routinely been used to recover organisms causing urinary tract infections. However, organisms grown on these media usually require further differentiation and identification, increasing the turn around time and workload.</p> <br /> <p><b>Spectra UTI</b> is a chromogenic medium that will grow, differentiate, and presumptively identify common urinary tract infections, reducing turn around time and improving laboratory efficiency. The medium contains two chromogens which react with specific enzymes present in urinary tract pathogens to produce uniquely colored colonies. In addition, phenylalanine and tryptophan are added to the medium for the detection of <i>Proteus</i> spp., <i>Morganella</i> spp., and <i>Providencia</i> spp., while at the same time retarding or inhibiting the swarming of <i>Proteus</i>.</p> <br /> <p>Common urinary tract organisms easily cultured and differentiated on <b>Spectra UTI</b> are <i>E. coli</i>, enterococci, <i>Klebsiella</i>, <i>Enterobacter</i>, <i>Serratia</i>, <i>Proteus</i>, <i>Morganella</i>, <i>Providencia</i>, <i>Pseudomonas</i>, <i>Staphylococcus aureus</i>, <i>Streptococcus agalactiae</i>, and <i>Staphylococcus saprophyticus</i>. View the <a href="[PATH]PDF/Spectra UTI-lowres.pdf">Spectra UTI brochure</a> to learn more.</p> <br /> </div> <div><b>Spectra UTI</b> <ul> <li>Improves work flow</li> <li>Saves time</li> <li>Reduces the number of confirmatory tests</li> <li>Improves accuracy</li> </ul> <br /> </div>

...read more ...

New QC Organism Look-up Tool Now Online

9/22/2010

<div><p>Stringent Quality Control ensures reproducible clinical test results and consistent microbiological evaluation of pharmaceuticals and food. The quality of your results and products is important. Remel brand quality control products are available in over 600 strains and in multiple formats to meet your laboratory's needs.</p> <br /> <p>Finding order information for the Remel QC organism strain you need in the format you want just got easier. Check out our new <a href="[PATH]support/qclookup.aspx">QC Organism Look-up Tool.</a> It allows you to search by genus, species, or ATCC<sup>&reg;</sup> reference number and quickly returns the order information for the organism or strain you need for all available formats.</p> <br /> <p><a href="[PATH]support/qclookup.aspx">Look up an organism now.</a> <br /> <br /> <br /> </div>

...read more ...

RapID&trade; Demonstration Video Now Online

8/23/2010

<div><p>Implementing RapID&trade; systems in your laboratory just got easier. A demonstration video is now available 24/7 on our web site. Since each system uses a common procedure, the video shows you how simple it is to use: RapID ANA II (anaerobes), CB Plus (<i>Corynebacterium</i>), NF (non-fermenters), NH (<i>Neisseria/Haemophilus</i>), ONE (oxidase negative <i>Enterobacteriaceae</i>), SS/u (urinary tract pathogens), Staph Plus, STR (streptococci), and Yeast Plus. </p> <br /> <p>View the video <a href="[PATH]promotions/rapid/default.aspx">now</a> and share it with all your colleagues in the lab.</p> <br /> <p>Remel RapID&trade; Systems offer an easy-to-use economical solution for manual identification of organisms and as companion confirmation for automated systems. Collectively, all 9 systems can accurately identify more than 400 medically important organisms in four hours. Easy-to-read color reactions from a single one-step inoculation and 4 hour aerobic incubation make these tests extremely convenient and useful in the laboratory.</p> <br /> <ul> <li>Rapid, accurate identification of over 400 medically important organisms</li> <li>Simple, one-step inoculation</li> <li>4-hour aerobic incubation time</li> <li>Easy-to-read color reactions</li> <li>Extensive support with ERIC<sup>&reg;</sup> electronic compendium</li> </ul> <br /> <br /> </div>

...read more ...

Remel products facilities and administrative offices are going green to help the environment

8/9/2010

<br /><p>We believe in the responsible use of natural resources and strive for continuous improvement in our efforts to help the environment. Every day we make new strides in sustainability to reduce, reuse, and recycle. We invest in new technology and equipment, apply energy-efficient tools and techniques in our operations, and encourage our employees to live and work in an evironmentally friendly way. <a href="/promotions/green/default.aspx">Learn More.</a></em></p></br>

...read more ...

Thermo Fisher Scientific Receives FDA Clearance of Spectra<sup>&trade;</sup> VRE

7/27/2010

<div><p><strong><i>Test is First Chromogenic Media to Detect Colonization in 24 Hours with No Required Confirmatory Testing</i>.</strong></p> <br /> <p>LENEXA, Kansas, (July 27, 2010) – Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it received U.S. Food and Drug Administration (FDA) clearance for <a href="http://www.remel.com/Catalog/Item.aspx?name=Spectra%-26trade%-3b+VRE"> Spectra&trade; VRE,</a> a test designed to screen for vancomycin-resistant <i>Enterococcus</i> (VRE). Spectra VRE is the first chromogenic media for the 24-hour detection of VRE colonization with rectal swabs and stool specimens. Spectra VRE is manufactured, distributed, and sold by Remel, a product brand of Thermo Fisher Scientific.</p> <br /> <p>Vancomycin-resistant <i>enterococci</i> (VRE) are the third leading cause of healthcare associated infections resulting in higher morbidity, mortality, and hospital costs.<sup>1, 2</sup> VRE colonization can progress to infection, especially for people with certain risk factors.<sup>3</sup> Proactive VRE screening is an important part of an infection control and prevention program to reduce the spread within the hospital. The potential exists for VRE to transfer genetic vancomycin resistance to other gram-positive organisms, especially methicillin-resistant <i>Staphylococcus aureus</i>, creating vancomycin-resistant <i>S. aureus</i> (VRSA). To date, eleven cases of VRSA have been reported in the U.S., and it remains a serious public health concern due to limited treatment options.<sup>4</sup></p> <br /> <p><a href="http://www.remel.com/HAI/VREArticles.aspx"target="_blank">read more</a></p> <br /> <br /> </div>

...read more ...

Isolator Wrap<sup>&trade;</sup> Sterile Contact Plates Now Available from Thermo Fisher Scientific

5/25/2010

<div> <p>The <a href="http://www.remel.com/Promotions/sterilecontactplates/"target="_blank">Isolator Wrap</a>&trade;</a> Sterile Contact Plates are for surface sampling in isolator environments and provide the critical confidence you require. The media are dispensed into GripFit&trade; petri dishes which prevent the lids and bottoms from separating when picked up, but also allows for easy removal of the lids, even with one hand. The plates are labeled on the bottom so the information (lot number, expiration date) stays with the sample to prevent mixups. The GripFit&trade; contact plates are contained in protective outer barrier wraps, which are impermeable to isolator decontamination procedures but maintains the integrity of the media inside. The plates are shrink-wrapped with easy-to-open tear strips. The shrink-wrap maintains moisture levels, prevents breakage, and provides a 6-month shelf life. An extra sterile bag is provided in each Isolator Wrap package for use in transporting the plates to the laboratory for testing after the samples have been obtained. The Isolator Wrap plates are manufactured in a Class 10,000 (ISO Class 7) cleanroom with Class 100 (ISO Class 5) work zones and then are irradiated to ensure a Sterility Assurance Level of 10<sup>-6</sup> for the finished products.</p> <br /> </div>

...read more ...

RapID&trade; QC Report Forms Now Online

4/16/2010

<div><p><a href="http://www.remel.com/Clinical/Microbiology/DiagnosticTests/RapIDSystem.aspx"target="_blank">RapID</a>&trade;</a> sytems are ideal for manual testing and as companion confirmation tests for automated systems. Use RapID systems to accurately identify more than 400 medically important organisms in four hours. Easy-to-read color reactions from a single one-step inoculation and 4 hour aerobic incubation make these tests super convenient.</p> <br /> <p>And now validating these systems just got easier. <a href="http://www.remel.com/Clinical/DiagnosticTests/RapIDQCReportForms.aspx"target="_blank">QC Report Forms</a> for each of the nine RapID Systems are now availble 24/7 on our web site. Each form includes key indicator strains and corrective action steps. Print as needed and never be without your QC documentation again.</p> <br/> </div>

...read more ...

The Latest Remel Products Catalog is Now Available

2/22/2010

<div><p>The 2010-11 Remel Products Catalog is now available in print and online. The latest edition includes many customer-centric enhancements. The new format makes it easier to locate products and is more environmentally friendly. All catalog items were recently updated on remel.com, and a pdf version of the printed catalog is also available.</p><br /> <p>There were many updates made to the latest edition in an effort to help customers navigate through the thousands of products available in our portfolio. The Remel product portfolio covers a wide range of microbiology products from specimen collection and transport, to identification, to quality control. Some of the many catalog upgrades and enhancements include:</p><br/> <ul> <li>New and improved Diagnostic Tests section with complete alphabetical listing and a new Diagnostic Tests Quick Reference Guide sorted by organism</li> <li>Expanded Product Usage Guide for fast look-up by organism and then by workflow</li> <li>Expanded Alphabetical Index with more key words</li> <li>New photos throughout, plus photos added to the online catalog</li> </ul> </div> <br /><p>The expert team that supports Remel products has a strong reputation for quality and reliability, and each and every team member is committed to providing exceptional customer support and on-time delivery. Our catalog and web site are designed with customers in mind. Check them out for yourself then <a href="http://www.remel.com/Support/RequestCatalogForm.aspx"target="_blank">contact</a> a Remel representative who is ready to assist you.</p><br/> <p><a href="http://www.remel.com/Catalog.aspx"target="_blank">Browse our catalog now</a><br /> <p><a href="http://www.remel.com/Support/RequestCatalogForm.aspx"target="_blank">Request a Catalog</a><br /> <br/>

...read more ...

Xpect<sup>&reg;</sup> RSV IFU Update: Additional transport media validated for compatibility with Xpect RSV (R24601)

2/15/2010

<p>Xpect<sup>&reg;</sup> RSV IFU Update Effective February 2, 2010: Additional transport media validated for compatibility with <br />Xpect RSV (R24601).</p> <p>The following transport media have been evaluated and found to be compatible with the Xpect RSV Test Kit.</p> <div style='margin-left:25px;'> <ul> <li>Earle’s Minimum Essential Medium (EMEM)</li> <li>EMEM with 1% Lactalbumin Hydrolysate</li> <li>M4<sup>&reg;</sup></li> <li>M4RT<sup>&reg;</sup></li> <li>M5<sup>&reg;</sup></li> <li>M6" (updated)</li> <li>Phosphate Buffered Saline (PBS)</li> <li>PBS with 0.5% Bovine Serum Albumin</li> <li>PBS with 0.5% Gelatin</li> <li>Saline (normal)</li> <li>Todd Hewitt Broth</li> <li>Tryptic Soy Broth</li> <li>Viral CULTURETTE" </li> </ul> </div> <br /> <br /> <p>Please contact Remel <a href="[PATH]Support/TechSupport.aspx">Technical Service</a> at 800.255.6730 if you have any questions or require any assistance with Remel products. </p> <br /> <br />

...read more ...

Thermo Fisher Scientific Improves Detection of <i>Bacillus cereus</i> Microorganisms in Food

1/19/2010

<div><p>Lenexa, Kan. (January 19, 2010) – Thermo Fisher Scientific Inc., the world leader in serving science, reports that its agar for identifying <a href="http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensNaturalToxins/BadBugBook/ucm070492.htm"><i>Bacillus cereus</i></a> <i>(B. cereus)</i> can accurately test food and beverages for this illness-causing microorganism. <i>Brilliance</i>&trade; Bacillus cereus Agar allows laboratories to significantly improve the detection and recovery of <i>B. cereus</i>. Food microbiologists in both manufacturing companies and research laboratories rely on <i>Brilliance</i> Bacillus cereus Agar for rapid identification of the bacterium.</p><br/> <p>With <i>Brilliance</i> Bacillus cereus Agar, <i>B. cereus</i> is quickly isolated, appearing as colored colonies for precise identification. Food manufacturers can rapidly extract <i>B. cereus</i> if present, investigate the cause of the contamination and, if necessary, alert consumers.</p><br/> <p>“Although <i>B. cereus</i> poisoning is largely underreported, the recent voluntary recall of ready-to-drink Slim-Fast&trade; products in the United States and Canada, for example, underscores the need for more vigilant testing,” said Ali Ball, vice president of marketing and new product development for the Thermo Fisher Scientific microbiology business. “We are committed to providing quality products and solutions to help food manufacturers avoid costly recalls or outbreaks and, most importantly, to protect consumers from the consequences of <i>B. cereus</i> poisoning.”</p><br/> <p>Researchers at the U.S. Centers for Disease Control and Prevention estimate that approximately 27,000 cases of <i>B. cereus</i> food poisoning occur each year. However, only 72 were officially reported (none of these in connection with the Slim-Fast&trade; product recall) during the most recent yearly analysis. This is, at least in part, because <i>B. cereus</i> poisoning symptoms – nausea, vomiting, abdominal cramps and diarrhea – closely resemble those of staphylococcal (<a href="http://www.fda.gov/Food/FoodSafety/FoodborneIllness/FoodborneIllnessFoodbornePathogensNaturalToxins/BadBugBook/ucm070015.htm"<i>Staphylococcus aureus</i></a>) food poisoning, resulting in misdiagnosis and under-reporting.</p><br/> <p><i>B. cereus</i> contamination typically occurs when foods are prepared and held without refrigeration for several hours before serving. For more information about the <i>Brilliance</i> Bacillus cereus Agar, please visit: <a href="http://www.remel.com/chromogenicmedia">www.remel.com/chromogenicmedia</a>.<br/> </p><br/></div>

...read more ...

Xpect<sup>&reg;</sup> Flu A&B IFU with FDA clearance to include new analytical reactivity information for the 2009 H1N1.

10/20/2009

<p>The <a href="[PATH]Clinical/Virology/Xpect.aspx">Xpect<sup>&reg;</sup> Flu A&B</a> Instructions for Use (package insert) has been revised to include additional analytical reactivity information for two H1N1 strains including the 2009 H1N1 Influenza A/California/04/2009.</p> <br/> <p>Although Xpect Flu A&B has been shown to detect the novel influenza (H1N1) virus in cultured isolates from a positive human specimen, the performance characteristics of the device with human specimens infected with the 2009 H1N1 influenza virus have not been established. Xpect Flu A&B can distinguish between influenza A and B viruses, but it does not differentiate influenza subtypes.</p><br/>

...read more ...

Xpect<sup>&reg;</sup> Flu A&B IFU Update: Additional transport media validated for compatibility

9/8/2009

<p>Xpect<sup>&reg;</sup> Flu A&amp;B IFU Update Effective August 18, 2009: Additional transport media validated for use with Xpect <sup>&reg;</sup> Flu A&amp;B (R24600).</p> <p>The following transport media have been evaluated and found to be compatible with the Xpect<sup>&reg;</sup> Flu A&amp;B Test Kit.</p> <div style='margin-left:25px;'> <ul> <li>Amies Medium</li> <li>Bartels Viral Transport Medium</li> <li>BD" Universal Viral Transport System (updated)</li> <li>Cary Blair Medium</li> <li>Copan Universal Transport Medium (updated)</li> <li>Earle’s Minimum Essential Medium (EMEM)</li> <li>EMEM with 1% Bovine Serum Albumin</li> <li>EMEM with 1% Lactalbumin Hydrolysate</li> <li>Hank’s Balanced Salt Solution</li> <li>Liquid Stuarts Medium</li> <li>M4<sup>&reg;</sup></li> <li>M4RT<sup>&reg;</sup></li> <li>M5<sup>&reg;</sup></li> <li>M6" (updated)</li> <li>Phosphate Buffered Saline (PBS)</li> <li>PBS with 0.5% Bovine Serum Albumin</li> <li>PBS with 0.5% Gelatin</li> <li>Saline (normal)</li> <li>Sucrose Phosphate</li> <li>Tryptic Soy Broth with 0.5% Bovine Serum Albumin</li> <li>Tryptic Soy Broth with 0.5% Gelatin</li> <li>Veal Infusion Broth</li> <li>Veal Infusion Broth with 0.5% Bovine Serum Albumin</li> </ul> </div> <br /> <br /> <p>Please contact Remel <a href="[PATH]Support/TechSupport.aspx">Technical Service</a> at 800.255.6730 if you have any questions or require any assistance with Remel products. </p> <br /> <p><a href="[PATH]PDF/Xpect%20Flu%20AB%20Technical%20Bulletin0909.pdf" target="_blank">Printer Friendly Version (PDF)</a> </p> <br /> <br />

...read more ...

New Tool to Update Iodine Registration Information

8/31/2009

<div> <p>A new web tool was added to Remel.com today that allows customers who are authorized iodine purchasing agents to update their registered email, phone, and fax information. To speed up the process and ensure accuracy of the information, authorized agents can now submit changes to us directly from our website 24 hours a day, seven days a week. </p> <br /> <p> In order to comply with the regulations enacted by the Drug Enforcement Administration and the Controlled Substances Act, all iodine-related requests submitted through the tool must be confirmed and authenticated by the authorized purchasing agent on file before the request can be processed. Authorized iodine purchasing agents must respond to the authentication email that follows to complete the request. Changes beyond email, phone, and fax will require a new <a href="[PATH]Promotions/Iodine/OnlineRegistration.aspx">Proof of Identity</a> registration. Contact <a href="[PATH]Support/CustomerService.aspx">Customer Service</a> for assistance as needed. </p> <br /> <ul> <li> <a href="[PATH]promotions/iodine/registrationupdate.aspx">Update Registration Info</a> </li> <li> <a href="[PATH]News/Releases/Article.aspx?id=3">Iodine Product Guidelines</a> </li> </ul> </div> <br />

...read more ...

Remel Offices Closed Monday, Sept. 7

8/21/2009

<p>On Monday, September 7, 2009, our offices will be closed in observance of the Labor Day holiday. No orders will be taken or shipped on this date. Normal business hours, and operation, will commence on Tuesday, September 8. </p><br/>

...read more ...

Remel Introduces New Saline 0.45% (3.0 ml in Plastic Tube)*

5/21/2009

<div><p>Lenexa, Kan., (May 21, 2009) – Thermo Fisher Scientific, the world leader in serving science, announced a new product, Saline 0.45% (3.0 ml) in a plastic tube with screw cap for use with automated ID/AST (identification/antimicrobial susceptibility test) systems, specifically the Vitek<sup>&reg;</sup> 2, manufactured by bioMérieux, Inc. In addition, the company also announced the modification to an existing product, Saline 0.45% (1.8 ml), to be manufactured with the same plastic tube and screw cap. The 1.8 ml product is used with the legacy Vitek<sup>&reg;</sup> system.</p><br/> <p>The Saline 0.45% is contained in an easy-to-use plastic tube that is optically clear for ease in adjusting the organism density in the saline in order to standardize the inoculum strength and is also convenient for reading with a Vitek densitometer. By using the Saline 0.45% (3.0 ml), users can eliminate the multi-step process and contamination risk associated with dispensing saline from a large bottle into a small useable plastic tube. Both Saline 0.45% products (1.8 ml and 3.0 ml) can be easily stored, transported, and used with reduced risk of breakage or spillage. The tubes are pre-filled and ready for use.</p><br/> <p>“The new plastic tube being used with these products will offer increased safety for people working in the laboratory and will make their jobs easier to perform,” says Andy Thomson, vice president and general manager, Microbiology North America at Thermo Fisher Scientific.</p><br/> <p>The plastic tube is ideal for preventing accidental breakage while in the instrument, thereby reducing downtime, costs for cleanup, and reducing the potential risk for exposure to a potentially infectious agent.</p><br/> <p>The Remel Saline 0.45% in the new plastic tube provides safety, convenience, and ease-of-use when performing automated identification and antimicrobial susceptibility testing.</p><br/> <p><a href="http://www.remel.com/Promotions/Vitek/"target="_blank">Learn More</a> <br/> <br/> <br/>

...read more ...

Remel Contact Plates for Environmental Monitoring <br/>Featuring GripFit&trade; Technology

5/4/2009

<div><p>Lenexa, Kan., (April 1, 2009) – New and improved GripFit&trade; plates are now available on Remel Contact Plates for environmental monitoring. The new lid design features a snug fit lid that makes one-handed plate handling easier while minimizing the risk of contamination due to inadvertent lid slippage during plate handling.</p><br/> <p>In order to assure sterility during environmental monitoring, contact plate lids must fit snuggly, but must be easy to remove with one hand. This minimizes the risk of contaminating other areas of the clean room or isolator with a second hand, which can hold other reagents, pipettes, or laboratory tools. Remel Sterile Contact Plates with the new GripFit&trade; technology are easier to use in sterile environments and help to ensure the safety and quality of pharmaceutical and biotechnology products.</p><br/> <p>Remel Sterile Contact Plates are double bagged and have a third bag enclosed for plate transport. These products are manufactured in a Class 10,000 (ISO Class 7) validated Clean room with Class 100 (ISO Class 5) work zones and are validated to be sterile by gamma radiation with a sterility assurance level of 10-6. From Quality Control organisms (ATCC<sup>&reg;</sup> Licensed Derivative&trade; Program Member) to microbial media for Microbial Limits Testing (MLT) and Sterility Testing as well as media for environmental monitoring and quality assurance testing needs, Remel has the complete portfolio of products necessary to meet pharmaceutical and biotech manufacturers’ regulatory guidelines for validation and testing. For more information or to request a product evaluation, visit us <a href="http://www.remel.com/Promotions/SterileContactPlates"target="_blank">online.</a></p></div>

...read more ...

Remel Spectra&trade; MRSA Wins <br/>Medical Design Excellence Award

4/9/2009

<p><strong>Thermo Fisher Scientific recognized for innovation in developing a reliable, economical solution to help control and prevent the spread of MRSA.</strong></p> <br /> <div><p>Waltham, Mass., (April 24, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Spectra&trade; MRSA is a winner in the 2009 Medical Design Excellence Awards competition in the category of in vitro diagnostics. Spectra MRSA is a chromogenic culture medium for the detection of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA), which aids in the control and prevention of MRSA in healthcare settings. This powerful solution offers the highest Positive Predictive Value (98.1%) of any MRSA test on the market. Pressures are mounting on healthcare organizations to reduce hospital acquired infections like MRSA and also to control associated costs. Affordable and easy to use, Spectra MRSA is designed to help healthcare organizations screen more patients on more shifts in more hospitals.</p> <br/> <p>“The design of Spectra MRSA combines the simplicity of microbiological culture media with the high-value and accuracy expected from a diagnostic test,” said Tom Floyd, president, microbiology products, Thermo Fisher Scientific. “It is truly a practical, high-performing solution to a pathogen that is causing serious public health concerns. We are honored that Spectra MRSA is being recognized with a Medical Design Excellence Award and proud to deliver a solution that makes an impact in how hospitals fight MRSA.”</p> <br/> <p>The Medical Design Excellence Award, organized and presented by Canon Communications LLC (Los Angeles), is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Spectra MRSA was evaluated and selected for the award based on its design features and user-related functions that improve healthcare, and for providing enhanced benefits to patients.</p> <br/> <p>Spectra MRSA received FDA clearance in February 2008, amidst growing concerns about the spread and danger of MRSA. The Centers for Disease Control and Prevention (CDC) is currently estimating two million healthcare associated infections, 99,000 associated deaths each year in the U.S. and over $4.5 billion to $6.5 billion in treatment costs and excess hospital days. According to a 2007 study by the Association for Professionals in Infection Control and Epidemiology, 1.2 million U.S. hospital patients may be infected with MRSA each year, and up to 119,000 hospital patients each year may die from MRSA. Spectra MRSA is well positioned to economically assist hospitals in their quest to control these types of infections.</p> <br/> <p>Spectra MRSA is manufactured, distributed, and sold in the U.S. under the Thermo Fisher Scientific specialty brand, Remel. To learn more about Spectra MRSA, visit us <a href="http://www.remel.com/Promotions/MRSA" target="_blank">online.</a> </p> </div><br />

...read more ...

Thermo Fisher Scientific Testing Method Approved For Detecting Salmonella in Food

4/6/2009

<div><p>AOAC Grants Performance Testing Methods Status to Salmonella Rapid Culture Method that Delivers Results in Less than 48 Hours</div></p> <div><p>WALTHAM, Mass. (April 3, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced availability of a testing method that it has developed to help food producers detect deadly Salmonella contamination in their products. The Salmonella Rapid Culture Method delivers highly accurate results in less than 48 hours, compared to up to four days for other methods. The Association of Analytical Communities (AOAC) granted Performance Testing MethodsSM status to this new testing solution.</p> <p>The Salmonella Rapid Culture Method employs two novel culture products in a simple two-step procedure. The AOAC granted Performance Testing Methods status after trials demonstrated that the method delivered consistent, accurate results that can allow food companies to confirm their products are free from Salmonella. For more than 120 years, AOAC has been a proactive, worldwide provider and facilitator in the development, use and harmonization of validated analytical methods and laboratory quality assurance programs and services.</p> <p><br/><a href="http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-newsArticle&ID=1273269" target="_blank">read more...</a></p><br/></div>

...read more ...

New Remel VACC Agar Now Available

12/12/2008

<div><p>Remel VACC Agar is now available for primary, selective isolation of ESBL (Extended-Spectrum ß-Lactamase) producing <i>Enterobacteriaceae</i>. ESBL-producing gram-negative bacilli are increasingly important nosocomial pathogens in healthcare facilities.<sup>1</sup> ESBLs inactivate broad-spectrum cephalosporins, such as cefotaxime and ceftazidime and cause clinically significant resistance in several strains of <i>Enterobacteriaceae</i>. For more information, contact your local Technical Sales Representative.</p> <p><a target="_blank" href="../../PDF/VACC Agar.pdf">Product Information Sheet</a></p> <p><a target="_blank" href="../../Support/MyRemelOnline/IFU.aspx">Instructions For Use</a> (Product No. R01954)</p> <hr style="width:100px;text-align:left;margin-left:15px;" /> <p style="font-size:6.5pt">1. Paterson, D.L. and R.A. Bonomo. 2005. Clin. Microbiol. Rev. 18:657-686.</p> <br /> </div>

...read more ...

New Remel RPMI 1640 Agar w/MOPS and 2% Glucose Now Available

11/4/2008

<div> <p>Remel RPMI 1640 Agar w/MOPS and 2% Glucose is now available as an FDA cleared In Vitro Diagnostic product for use with the gradient-strip method for susceptibility testing of antifungal agents when testing Candida spp. directly from colonies grown on nonselective media. Used to determine MIC values for various antifungal agents, RPMI 1640 Ager 150mm plates offer a simple, convenient way to apply multiple antifungal gradient-strips with results in 24 hours. For more information, contact your local Technical Sales Representative.</p> <p><a target="_blank" href="../../PDF/RPMIw2PercentGlucose.pdf">Product Information Sheet</a></p> </div> <p><a target="_blank" href="../../Support/MyRemelOnline/IFU.aspx">Instructions For Use</a>(Product No.R04067)</p>

...read more ...

Remel to Supply Microbiology Products to MedAssets Supply Chain Systems

9/11/2008

<div><p>LENEXA, Kan. (September 15, 2008) – Remel, part of Thermo Fisher Scientific, the world leader in serving science, announced today that it has signed a supply agreement with MedAssets Supply Chain Systems, a MedAssets company, to supply manual microbiology products and services to MedAssets customers through September, 2011. MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency.</p> <p><a href="[PATH]PDF/ThermoFisher MedAssets 9_11_final.pdf" target="_blank">read more...</a></p><br /></div>

...read more ...

Remel to Supply Microbiology Products to MedAssets Supply Chain Systems

9/11/2008

<div><p>LENEXA, Kan. (September 15, 2008) – Remel, part of Thermo Fisher Scientific, the world leader in serving science, announced today that it has signed a supply agreement with MedAssets Supply Chain Systems, a MedAssets company, to supply manual microbiology products and services to MedAssets customers through September, 2011. MedAssets partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency.</p> <p><a href="[PATH]PDF/ThermoFisher MedAssets 9_11_final.pdf" target="_blank">read more...</a></p><br /></div>

...read more ...

MSDS Document Receipt Registration

5/28/2008

<div><p>We are committed to providing you with exceptional customer service and technical support in order to exceed your expectations on a daily basis. Today we are taking steps to make it faster and easier for you to obtain our Material Safety Data Sheets (MSDSs). We understand these documents are critical to your organization, and we want to make the process of receiving them as timely and as simple as possible for you.</p><br /><p>Beginning September 2008, a new system will be implemented that will allow us to automatically fax or e-mail MSDSs to you for new orders and on a routine basis, ensuring that we comply with industry regulations. We invite you to follow the registration steps below so that you are ready to take full advantage of the power that this new system offers. Please note that MSDSs will still be accessible on-line 24/7 via the support area of remel.com.</p><p>To register on-line, click <a href="[PATH]Promotions/MSDS/OnlineRegistration2.aspx">here</a>.</p> <p>To update your registration, click <a href="[PATH]Promotions/MSDS/OnlineRegistration2.aspx">here</a>.</p></div>

...read more ...

What We Do Matters – Watch New Video to Learn How

5/21/2009

<div><p>What we do in microbiology matters to each and every one of us at Remel. With a relentless focus on our industry and our corporate values – integrity, intensity, innovation and involvement – Remel employees deliver high-quality products, on-time delivery and superior service each day for our customers. Ultimately, everything we do supports our mission – to enable our customers to make the world healthier, cleaner and safer.</p> <p><a href="http://www.remel.com/About.aspx"target="_blank">Watch</a> our new video and learn why what we do matters to you.<br/></p> </div>

...read more ...

All Technical Documents Now Available Without Login

7/3/2008

<div><p>As part of our continued commitment to providing quality products, on-time delivery, and superior service and support, we have recently taken steps to make technical documents even faster and easier to obtain. </p> <p>Effective immediately, registration to MyRemelOnline is not required for online access to technical documents. Now, you can access all of our documents by a simple product or lot number and a click of the mouse. Technical documents include Instructions For Use(IFU), Material Safety Data Sheets (MSDS), CLSI procedures, and Certificates of Quality. Go to the Support page and click on the link to the document you are looking for. If you cannot find what you need, complete our online <a href="[PATH]Support/MyRemelOnline/RequestDocument.aspx">Document Request Form</a>, which will go directly to a Technical Service representative who is ready to help you. </p></div>

...read more ...

Ribbon cutting in Lenexa celebrates growth and success of Microbiology division

5/30/2008

<div><p>Thursday, May 29, we hosted a ribbon cutting event to celebrate the recent expansion to our Lenexa Microbiology operation and to bring awareness to the local community that we are one of the area’s largest scientific employers. City and state government officials were present to acknowledge the importance of the event and to join with other local Bioscience leaders and business partners to tour the facility, network with each other, and celebrate the event with a representative set of employees. It was a wonderful opportunity to reach out to the local community and remind people that we are a great place to work and that we are doing great things to make the world healthier, cleaner, and safer through Microbiology.</p> <br /> <p>The Lenexa operation develops, manufactures and supports Remel brand products, a portfolio of high quality products used by clinical, industrial, research, and academic laboratories. The Remel products portfolio includes over 6000 items. Items include dehydrated and prepared culture media, collection and transport systems, diagnostic and rapid direct specimen tests, quality control products, and other laboratory supplies. The expansion project recently completed was targeted at one of four Microbiology facilities in Lenexa. This particular facility went from general office and warehouse space to a now state-of-the-art manufacturing, scientific development, training, and administration facility. The new space is occupied by approximately 40 employees and is now home to our Dehydrated Culture Media operation, MPD lab (Media and Process Development), new Chemistry lab, and fully equipped training and presentation facilities.</p> <br /> <img src="../../images/misc/RibbonCuttingWeb.jpg" alt="Ribbon Cutting Event at Lenexa facility" /> <p><i>From left: JR Robl, KS Dept. of Commerce; Janice Katterhenry, Kansas Bioscience Authority; Mike Boehm, Mayor of Lenexa; Tom Wilson, Thermo Fisher Scientific; Tom Thornton, Kansas Bioscience Authority; Craig Knutzen, Thermo Fisher Scientific</i></p> <br /> <p>Tom Wilson, Vice President and General Manager for Thermo Fisher Scientific, Microbiology NA, hosted the event. “This expansion positively affects all elements of our Lenexa operation,” Wilson said. “We are creating new products for our market, new service levels for our customers and new jobs for our community.” </p> <br /> <p>“Our vision is to be the preferred partner for our customers and a world leader in Microbial Diagnostics.” Wilson said. “Today we are realizing this desired outcome thanks to a cooperative effort between Thermo Fisher Scientific, the Kansas Bioscience Authority, the Kansas Department of Commerce and local Lenexa government.” </p> <br /> <p>The recent expansion was made possible in large part by a recent investment from the Kansas Bioscience Authority (KBA), which agreed to invest up to $1.25 million over the next five years as we continue to invest in our local Microbiology operation and expand our local workforce. Tom Thornton, president and CEO for the KBA, spoke at the event and recognized how truly important Thermo Fisher Scientific is to the state. He commended the company for its commitment to innovation and to developing products that make a difference in the lives of Kansans. “Kansas ranks 2nd in the United States for clinical research facilities,” Thornton said. “You all are a significant contributor to that.” He also said “this is a fantastic company with fantastic employees. I am very proud to have the opportunity to be part of your growth and success. We wish you all the best.”</p> </div>

...read more ...

Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium

4/3/2008

<div><p>WALTHAM, Mass., April 3, 2008 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has received U.S. Food and Drug Administration (FDA) clearance for Spectra&trade; MRSA, a test designed to screen for methicillin-resistant Staphylococcus aureus (MRSA), more commonly known as the "superbug." With the highest Positive Predictive Value commercially available for MRSA screening, Spectra provides accurate results within 24 hours. The Spectra MRSA test is manufactured, distributed and sold under the Thermo Fisher specialty brand, Remel.</p> <p>MRSA has become a major public health concern, with occurrences on the rise in healthcare facilities nationwide. According to a recent report by the Association for Professionals in Infection Control and Epidemiology (APIC), MRSA is prevalent in 46 of 1,000 patients in the U.S. -- 8 to 11 times higher than previous estimates. Moreover, their findings suggest that MRSA, which is antibiotic-resistant and difficult to treat, may lead to as many as 119,000 patient deaths in U.S. hospitals annually.</p> <p><br /><a href="http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-newsArticle&ID=1125792" target="_blank">read more...</a></p><br /></div>

...read more ...

KBA and Thermo Fisher Scientific partner for growth in Lenexa

10/24/2007

<div><p>OLATHE, Kan. — The Kansas Bioscience Authority (KBA) and Thermo Fisher Scientific have concluded an agreement that will support a multi-million dollar expansion of Thermo Fisher Scientific's microbiology business unit in Lenexa, Kan., which manufactures and distributes Remel products to clinical, industrial, and academic laboratories around the world.</p><p><br /><a href="http://www.kansasbioauthority.org/news/Detail.aspx?id=33" target="_blank">read more...</a></p><br /></div>

...read more ...

ATCC Licensed Derivative<sup>&reg;</sup> Program

6/20/2007

<div><p>Remel Inc. has a license agreement with American Type Culture Collection (ATCC<sup>&reg;</sup>) regarding the manufacture, marketing, and sale of quality control microbiology products that incorporate microorganisms derived from ATCC cultures. The license agreement confirms Remel's participation in ATCC's Licensed Derivative<sup>&reg;</sup> Program and enables us to supply Quality Control microbiology products that incorporate organisms with identity, purity, and viability, which have been assured by ATCC. These include our market-leading Culti-Loops<sup>&reg;</sup> and Quanti-Cult<sup>&reg;</sup> product lines.</p><p><br />If you purchase quality control microbiology products from Remel, an authorized representative from your company must complete and submit an ATCC End User Agreement which includes commitments on the safe handling, usage, and disposal of products that contain licensed ATCC microorganisms ("Licensed Products"). The agreement must be completed to ensure uninterrupted delivery of Remel products containing licensed ATCC organisms. All products containing ATCC cultures shall be subject to an ATCC royalty fee.</p><p><br />Only Thermo Fisher Scientific entities are authorized to distribute Licensed Products manufactured by Remel.</p><p><br />Specific questions or concerns can be addressed by contacting your <a href="mailto:ICustomerSupport@remel.com">Customer Service Representative</a> at (800) 255-6730.</p><p><br />To register online, click <a href="[PATH]Promotions/ATCC/OnlineRegistration.aspx">here</a>.</p><br /></div>

...read more ...

Merger of Thermo Electron and Fisher Scientific Completed, Forming Thermo Fisher Scientific

11/9/2007

<div><p>New combined company creates the leading provider of products and services in the high-growth life, laboratory and health sciences industry</p><p><br />WALTHAM, Mass., Nov. 9 /PRNewswire-FirstCall/ -- Thermo Electron Corporation (NYSE: TMO) and Fisher Scientific International Inc. (NYSE: FSH) today announced that the merger of the two companies has been completed, creating Thermo Fisher Scientific Inc., the world leader in serving science. The companies combined in a tax-free, stock-for-stock transaction following anti-trust clearance received from the European Commission earlier today. The new company, headquartered in Waltham, Mass., has approximately $9 billion in revenues and 30,000 employees. Thermo Fisher Scientific will trade on the New York Stock Exchange under the symbol "TMO."</p><p><br /><a href="http://ir.thermofisher.com/phoenix.zhtml?c=89145&p=irol-newsArticle&ID=929319&highlight" target="_blank">read more...</a></p><br /></div>

...read more ...

Guidelines for Ordering Iodine Containing Products

6/26/2007

<div> <p> The Drug Enforcement Administration (DEA) enacted a final rule requiring the regulation of <strong><em>iodine</em></strong> as a List 1 chemical under the chemical regulatory provisions of the Controlled Substances Act (the “Act”). The Act requires that all manufacturers and distributors confirm the "proof of identity" of persons making regulated purchases of List 1 chemicals including iodine containing products. "Proof of identity" requires that positive identification and authorization status be established for all persons making regulated purchases of List 1 chemicals. </p> <p> <br /> <a target="_blank" href="[PATH]PDF/DEA_Regulated_Iodine_Containing_Products.pdf">DEA Regulated Iodine Containing Products</a> </p> <p> <br /> Remel Inc. is prohibited from processing orders for iodine containing products unless an authorized agent on record places the order. All authorized purchasing agents must fill out the <a href="[PATH]Promotions/Iodine/OnlineRegistration.aspx">Proof of Identity</a> form and submit it to Remel to ensure delivery of products containing iodine. Upon receipt by Remel, a password will be assigned and sent to the email address provided within one business day. <strong>This password, along with its associated authorized agent name, will be required when placing any orders for iodine containing products from Remel.</strong> </p> <p> <br /> All orders require an authorized purchasing agent name and password to be processed. A <a href="[PATH]PDF/Iodine_Order_Form.pdf">special order form</a> is available for convenience but is not required. Electronic (EDI) orders are not being accepted at this time for any Remel products containing iodine. </p> <p> <br /> If you have any questions regarding the completion of this form, please contact a Remel <a href="[PATH]/Support/CustomerService.aspx">Customer Service</a> Representative at 800-255-6730. </p><br /> <ul> <li> <a href="[PATH]Promotions/Iodine/OnlineRegistration.aspx">Authorized Agent Proof of Identity Registration</a> </li> <li> <a href="[PATH]promotions/iodine/registrationupdate.aspx">Update Registration Info</a> </li> <li> <a target="_blank" href="[PATH]PDF/Iodine_Order_Form.pdf">Special Order Form for Iodine Products</a> </li> <li> <a href="[PATH]Promotions/Iodine/RetrievePassword.aspx">Forgot your password?</a> </li> </ul><br /> </div>

...read more ...

CDC Revised Guidelines for Group B Strep

5/11/2007

<div> <p><a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5111a1.htm" target="_blank">CDC Revised Guidelines for Group B Strep</a></p> <script language="javascript" type="text/javascript"> window.open("http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5111a1.htm"); history.back(); </script> </div>

...read more ...